Central modulation of Brewer's yeast-induced peripheral inflammation by neuropeptides bradykinin and substance P

Indian Journal of Physiology and Pharmacology

Volumn 40, Issue 4, 1996, Pages 367-371

  Hore, Subrata K ^a   Tripathi, Harish C ^a   Tandan, Surendra K ^a   Kumar, Dinesh ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

bradykinin; Brewer's yeast; nociception; oedema; substance P

Indexed keywords

BRADYKININ; NEUROPEPTIDE; SUBSTANCE P;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; EDEMA; INFLAMMATION; MALE; NOCICEPTION; NONHUMAN; RAT;

ANALGESICS; ANIMALS; BRADYKININ; EDEMA; INFLAMMATION; MALE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; SACCHAROMYCES CEREVISIAE; SUBSTANCE P;

EID: 0029774436     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Colman RW, Wong PY. Kallikrein-Kinin systems in the pathological conditions. In "Handbook of Experimental Pharmacology Vol. XXV (Suppl.)" (E.G. Erdos ed.); pp 569-607, Springer-Verlag, New York, USA; 1979.
2. Clark WG. Kinins and peripheral and central nervous systems. In "Handbook of Experimental Pharmacology XXV (Suppl.)" (E.G. Erdos ed.); pp 311-356 Springer-Verlag, NewYork, USA; 1979.
3. Correa FMA, Graeff FG. Central mechanism of hypertensive action of intraventricular bradykinin in unanaesthetised rat. Neuropharmacology 1974; 13 : 65-74.
4. Kariya K, Yamauchi A, Chatani Y. Relationship between central actions of bradykinin and prostaglandins in conscious rat. Neuropharmacology 1982; 21 :267-272.
5. Moniuszko-Jakonium J, Wisniewski K. Activation of the kinin forming system and effect of thiopental. Psychopharmacology 1974; 40 : 269-277.
6. Riheiro SA, Corrado AP, Graeff IG. Antinociceptive action of intraventricular bradykinin. Neuropharmacology 1971; 725-731.
7. Inoki r, Kudo T, Yonehara N, Meda S, Saita K, Kotani Y, Matsuura H. Analgesic action of kinin administered intracerebroventricularly in mice. Agents Actions 1982; 9 (Suppl.). 270-275.
8. Mark JL. Brain Peptides: Is substance P a transmitter of pain signal?. Science 1979; 205 : 886-889.
9. Gilligan JP, Lovato SJ, Erion MD, Jeng AY. Modulation of carrageenin-induced hind paw oedema by substance P. Inflammation 1994; 18 : 285-292.
10. Stewart JM, Getto CJ, Nelder K, Reeve EV, Krivol WA, Zimmermann E. Substance P and analgesia. Nature 1976; 262 : 784-785.
11. Malick JB, Goldstein JM. Analgesic activity of substance P following intracerebral administration in rats. Life Sciences 1978; 23 : 835-844.
12. Starr MS, James TA, Gaytten D. Behavioural depressants and antinociceptive properties of substance P in mouse : Possible implications of brain monoamines. Eur J Pharmacol 1978; 48 : 203-212.
13. Hayes AG, Tyres MV. Effect of intrathecal and intracerebroventricular injections of substance P in nociception in rat and mouse. Br J Pharmacol 1979; 66 : 488.
14. Oehme P, Bergmann J, Bienert M et al. Biological actions of substance P - its differentiation by affinity and intrinsic efficacy. In "Substance P (Nobel) Symposium 37" (U.S. VonEuller, B. Pernow eds); pp 327-335 Raven Press, New York, USA; 1977.
15. Verster F, Robinson CA, Hangeveld CA, Bush ES. Free-hand cerebroventricular injection technique for unanaesthetized rats. Life Sci 1971; 10 : 1395-1402.
16. Howarth D, Carey F. In "Inflammatory Mediators" (C.A. Higgs, T.J. Williams Eds.); pp 37-45 VCH Publication, London; 1985.
17. Randall LO, Selitto J. A method for measurement of analgesic activity of inflammed tissue. Arch Int Pharmacodyn 1957; 111 : 209-219.
18. Snedecor GW, Cochran WG. In "Statistical Methods" (G.W. Snedecor, W.G. Cochran eds.) pp 3365 Oxford and IBH Publishing Co., 66, Janpath, New Delhi, India; 1967
19. Vinegar R. Traux JF, Selph JL, Johnston PR. In "Handbook of Experimental Pharmacology Vol. 50/ II" (J.R. Vane, S.H. Ferreira eds.); pp 209-222 Springer-Verlag, New York, USA; 1979.
20. Bhattacharya SK, Mohanrao PJR, Das N, Dasgupta G. Intracerebroventricularly administered bradykinin augments Carrageenin-induced paw oedema in rats. J Pharm Pharmacol 1988; 40 : 367-369.
21. Mcgiff JC, Terragno DA, Terragno NA, Colina J, Nasjletti A. In "Chemistry and Biology of Kallikreinkinin system in Health and Disease" (J.J. Pisano, K.F. Austen eds.); 267-273, NIH, Maryland; 1975.
22. Bhattacharya SK, Mohanrao PJR, Brumleve SJ, Parmar SS. Effects of intracerebroventricular administration of bradykinin on rat brain serotonin and prostaglandins. Res Comm Chem Pathol Pharmacol 1986; 54 :355-356.
23. Mohanrao PJR, Bhattacharya SK. Antinociceptive effect of intracerebroventricularly administered bradykinin in rats: Role of putative neurotransmitters. Ind J Exp Biol 1987; 25 : 315-318.
24. Dumka VK. Central modulation of formaldehyde-induced inflammation in rats. MVSc Thesis 1993, IVRI Izatnagar, India.
25. Kantor TG. The pharmacological control of musculoskeletal pain. Can J Physiol Pharmacol 1991; 69 : 713-718.
26. 26;. Thomas KL, Andrews PV, Khalil Z, Helme RD. Substance P-induced hydrolysis of inositol phospholipids in rat skin in an in vivo model of inflammation. Neuropeptides 1989; 13: 191-196.
27. McCarson KE, Goldstein BD. Time-course of the alteration in dorsal horn substance P level following formalin: Blockade by naloxone. Pain 1990; 41 : 95-100.
28. Baraniuk JN, Kowlski ML, Kaliner MA. Relationships between permeable vessels, nerves and mast cells in rat cutaneous neurogenic inflammation. J Appl Physiol 1990; 68: 2305-2311.
29. Barnes PJ, Belvisi MG, Rogers DF. Modulation of neurogenic inflammation: Novel approach to the inflammatory disease. Trends Pharmacol Sci 1990; 11: 185-189.
30. Culure R, Cuello AC. Studies on the trigeminal antidromic vasodilatation and plasma extravasation in the rat. J Physiol 1984; 346 : 273-285.
31. Coderre TJ, Vashpal K. Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamic and Substance P in rat formalin pain model. Eur J Neuroscience 1994; 6 : 1328-1334.